Inari Medical, Inc. (NASDAQ: NARI) reported Q1 EPS of ($0.42), $0.26 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $143.2 million versus the consensus estimate of $137.8 million.

GUIDANCE:

Inari Medical, Inc. sees FY2024 revenue of $592.5-602.5 million, versus the consensus of $587.9 million.

For earnings history and earnings-related data on Inari Medical, Inc. (NARI) click here.